Fig. 3

Immunohistochemical profile of leiomyosarcoma (LMS) (a) diffuse strong cytoplasmic positivity for Stathmin (b) Diffuse strong cytoplasmic positivity for Transgelin. (c) Diffuse nuclear negativity for BCOR (d) Diffuse nuclear negativity for Cyclin-D1. Streptavidine biotin method. Magnification (a) original magnification x 400 (b) original magnification x 400 (c) original magnification x 400 (d) Original magnification x 200